Comparison of Ruxolitinib and a Collagen-Targeted PTH-Based Hair Cycle Stimulant on Hair Follicle Counts and Hair Growth in the C3H/HeJ Engrafted Mouse Model of Alopecia Areata

    April 2023 in “ ˜The œjournal of investigative dermatology/Journal of investigative dermatology ”
    R.C. Gensure, B. King, S. Sikkink, A. Mardaryev, R. Goforth
    Image of study
    TLDR A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.
    The study compared the effects of a single subcutaneous injection of PTH-CBD and daily oral administration of the JAK inhibitor ruxolitinib on hair regrowth and anagen hair follicle counts in C3H/HeJ mice with alopecia areata over 8 weeks. Results showed that PTH-CBD treatment led to a significant increase in anagen hair follicles (p<0.05) and improved hair regrowth compared to ruxolitinib, despite similar immune cell infiltration. Additionally, PTH-CBD-treated mice exhibited increased beta-catenin production in hair follicles. The findings suggest that PTH-CBD can promote hair regrowth comparable to ruxolitinib, potentially by enhancing beta-catenin production and stimulating the anagen phase transition of hair follicles.
    Discuss this study in the Community →

    Related Community Posts Join

    4 / 4 results

      community Ruxolitinib - Start of a case study

      in Research/Science  10 upvotes 1 year ago
      The conversation is about a user trying a new hair loss treatment, Ruxolitinib, alongside their existing regimen of finasteride, minoxidil, ketoconazole shampoo, and microneedling. They plan to apply Ruxolitinib to their temples daily for 1-2 months.

      community No hair, don't care! [24/F] :)

       62 upvotes 9 years ago
      A woman with alopecia universalis shares her positive experience of being bald, finding it freeing and less worrisome. She also discusses her skincare routine using Korean products.

      community I had claude create a protocol only using fda approved drugs.

      in Research/Science  3 upvotes 2 weeks ago
      A new hair loss protocol using FDA-approved topical treatments targets eight pathways, potentially improving results by 60-75% compared to the standard 40-50% from oral minoxidil and finasteride. The protocol includes minoxidil, finasteride, tacrolimus, cetirizine, bimatoprost, lithium gluconate, losartan, melatonin, NAC, caffeine, and tretinoin, with a monthly cost of $35-50 in Mexico and $80-150 in the US.

      community What else is good. Besides the big 3.

      in Chat  35 upvotes 1 year ago
      Key treatments for hair preservation include minoxidil, finasteride/dutasteride, and microneedling, with additional options like specific shampoos, oils, biotin, zinc, tretinoin, clascoterone, and low-level laser therapy. Maintaining a healthy lifestyle, reducing stress, and addressing nutrient deficiencies can also support hair health.

    Related Research

    5 / 5 results